MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 10.02.2026
Medpace Holdings DPO 2011-2026 | MEDP
DPO Jährlich Medpace Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 13.3 | 12.5 | 23.3 | 16 | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 23.3 | 12.5 | 16.3 |
DPO anderer Aktien in der Diagnostik & Forschung
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Bioventus
BVS
|
35.1 | $ 9.26 | 1.09 % | $ 617 M |  USA |
 |
DarioHealth Corp.
DRIO
|
112 | $ 8.45 | 9.74 % | $ 33.7 M |  Israel |
 |
DexCom
DXCM
|
67.7 | $ 66.09 | -1.12 % | $ 25.8 B | USA |
 |
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
49.2 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M |  Britain |
 |
ICON Public Limited Company
ICLR
|
6.52 | $ 103.08 | 3.09 % | $ 8.5 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
24.9 | $ 573.29 | -0.42 % | $ 46.1 B | USA |
 |
Illumina
ILMN
|
56.3 | $ 124.4 | -1.43 % | $ 19.8 B | USA |
 |
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
112 | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
106 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | China |
 |
Myriad Genetics
MYGN
|
45.9 | $ 4.62 | -1.28 % | $ 428 M | USA |
 |
National Research Corporation
NRC
|
10.1 | $ 17.52 | 1.98 % | $ 392 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | USA |
 |
Natera
NTRA
|
17.9 | $ 196.15 | -0.62 % | $ 19.3 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
24.5 | $ 165.13 | -0.46 % | $ 8.18 B | USA |
 |
Organovo Holdings
ONVO
|
82.9 K | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
95 | - | -16.95 % | $ 1.54 M | USA |
 |
OPKO Health
OPK
|
43.1 | $ 1.17 | -1.68 % | $ 812 M | USA |
 |
Pacific Biosciences of California
PACB
|
59.7 | $ 1.35 | -2.88 % | $ 405 M | USA |
 |
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | USA |
 |
ENDRA Life Sciences
NDRA
|
1.65 K | $ 4.59 | 22.4 % | $ 2.46 M | USA |
 |
PerkinElmer
PKI
|
57.9 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
69 | - | - | $ 21.2 M | USA |
 |
Personalis
PSNL
|
67.3 | $ 7.32 | -4.94 % | $ 434 M | USA |
 |
Interpace Biosciences
IDXG
|
34.4 | $ 1.73 | 2.37 % | $ 7.59 M | USA |
 |
RadNet
RDNT
|
23.5 | $ 59.41 | -2.06 % | $ 4.47 B | USA |
 |
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
50 | - | - | $ 10.6 B |  Niderland |
 |
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | USA |
 |
Senseonics Holdings
SENS
|
68 | $ 6.56 | -2.96 % | $ 274 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
31.5 | $ 268.38 | 0.89 % | $ 22.3 B | USA |
 |
NeoGenomics
NEO
|
19.7 | $ 7.76 | -0.13 % | $ 994 M | USA |
 |
Soleno Therapeutics
SLNO
|
1.44 K | $ 31.83 | -0.03 % | $ 1.62 B | USA |
 |
Psychemedics Corporation
PMD
|
16 | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
53 | $ 27.2 | -0.15 % | $ 35.3 M | USA |